Comparative study of clinicopathologic features of oral and maxillofacial cancers in Cancer Registry System (Isfahan-Iran)

Razavi, Seyed Mohammad and Maleki, Laleh and Tahani, Bahareh and Behzadian, Ali and Rabbani, Hamed and Ravankhah, Zahra (2022) Comparative study of clinicopathologic features of oral and maxillofacial cancers in Cancer Registry System (Isfahan-Iran). Medical Journal of Tabriz University of Medical Sciences, 43 (6). pp. 506-514. ISSN 2783-2031

[thumbnail of mj-43-506.pdf] Text
mj-43-506.pdf - Published Version

Download (1MB)

Abstract

Background. Clinical and pathologic features of oral and maxillofacial malignant lesions are very important and useful in diagnostic and therapeutic planning. The aim of this study was to determine and compare the clinicopathologic features of different types of oral and maxillofacial cancers in Cancer Registry System at Isfahan-Iran.

Methods. In this cross-sectional descriptive analytic study, required data (tumor type, tumor location, age, sex, and grade of malignancy) of 1081 patients from Isfahan Cancer Registry collected.

Results. In this study, the mean age of the patients was 59.9±18.5years old. Most of the patients were male (56.43%). In this study, squamous cell carcinoma was the most common malignancy (61.9%) followed by non-Hodgkin's lymphoma (7%). The most common site was tongue (38.7%) and then the nasopharynx (13%). Also nasopharynx tumors in men were more common than women (P <0.001).

Conclusion. Squamous cell carcinoma, as the most common oral and maxillofacial cancer, requires considerable attention and rapid and appropriate diagnosis and treatment. Knowing the clinical and pathological features of this cancer and risk factors can improve the prognosis of patients.

Item Type: Article
Subjects: Open Research Librarians > Medical Science
Depositing User: Unnamed user with email support@open.researchlibrarians.com
Date Deposited: 10 Jun 2023 06:19
Last Modified: 23 Nov 2023 06:10
URI: http://stm.e4journal.com/id/eprint/1172

Actions (login required)

View Item
View Item